Advanced search
Publication Cover
Expert Review of Clinical Immunology Volume 18, 2022 - Issue 3: The JAKi in inflammatory disorders & arthritis: lights and shadows
Submit an article Journal homepage
2,850
Views
2
CrossRef citations to date
0
Altmetric
Editorial

How suitable are JAK inhibitors in treating the inflammatory component in patients with alopecia areata and vitiligo?

Emily C. Moyaa Center for Dermatology Research, Department of Dermatology, Wake Forest School of Medicine, Winston-Salem, NC, USACorrespondence[email protected]
,
Raquel L. Bruinsmaa Center for Dermatology Research, Department of Dermatology, Wake Forest School of Medicine, Winston-Salem, NC, USA
,
Katherine A. Kellya Center for Dermatology Research, Department of Dermatology, Wake Forest School of Medicine, Winston-Salem, NC, USA
&
Steven R. Feldmana Center for Dermatology Research, Department of Dermatology, Wake Forest School of Medicine, Winston-Salem, NC, USA;b Department of Pathology, Wake Forest School of Medicine, Winston-Salem, NC, USA;c Department of Social Sciences & Health Policy, Wake Forest School of Medicine, Winston-Salem, NC, USA;d Department of Dermatology, University of Southern Denmark, Odense, Denmark
Pages 189-191 | Received 24 Sep 2021, Accepted 28 Jan 2022, Published online: 06 Feb 2022

References

  • O’Shea JJ, Schwartz DM, and A. V V, et al. The JAK-STAT pathway: impact on human disease and therapeutic intervention. Annu Rev Med. 2015;66:311–28.
  • Montilla AM, Gómez-García F, and Gómez-Arias PJ, et al. Scoping review on the use of drugs targeting JAK/STAT pathway in atopic dermatitis, vitiligo, and alopecia areata. Vol. 9, Heidelberg, Switzerland: Dermatology and Therapy; 2019.
  • Garcia-Melendo C, Cubiró X, and Puig L. Janus kinase inhibitors in dermatology: part 1 — general considerations and applications in vitiligo and alopecia areata. Actas Dermo-Sifiliograficas. 2021;112:503–515.
  • El-Gayyar MA, Helmy ME, Amer ER, et al. Antimelanocyte antibodies: a possible role in patients with vitiligo. Indian J Dermatol. 2020;65:33–37.
  • Zhu MC, Liu CG, Wang DX, et al. Detection of serum anti-melanocyte antibodies and identification of related antigens in patients with vitiligo. Genet Mol Res: GMR. 2015;14(4):16060–16073.
  • Kemp E, Emhemad S, Gawkrodger D, et al. (2011). Autoimmunity in Vitiligo. https://doi.org/10.5772/20617.
  • Scheinberg M, Ferreira SB, Do Cb SD. Tofacitinib-induced remission simultaneously in arthritis and vitiligo. Eur J Rheumatol. [Internet]. 2021 Jan 28 [cited 2021 Aug 5];8:55. Available from: /pmc/articles/PMC7861634/.
  • Kubelis-López D, Zapata-Salazar N, Said-Fernández S, et al. Updates and new medical treatments for vitiligo (Review). Exp Ther Med. 2021;22. DOI:https://doi.org/10.3892/etm.2021.10229.
  • Darwin E, Hirt P, Fertig R, et al. Alopecia areata: review of epidemiology, clinical features, pathogenesis, and new treatment options. Int J Trichology. 2018;10:51.
  • Silpa-Archa N, Pruksaeakanan C, Angkoolpakdeekul N, et al. Relationship between depression and quality of life among vitiligo patients: a self-assessment questionnaire-based study. Clin Cosmet Investig Dermatol. 2020;13:511–520.
  • Khanna U, Khandpur S. What is new in narrow-band ultraviolet-B therapy for vitiligo? Indian Dermatol Online J. 2019;10(3):234–243.
  • Pratt H, King L Jr., Messenger A, et al. Alopecia areata HHS public access. Nat Rev Dis Primers. 2017;3. DOI:https://doi.org/10.1038/nrdp.2017.11.
  • Park H, Yu DA, Kwon O. Janus kinase inhibitors: an innovative treatment for alopecia areata. J Dermatol. 2019;46:724–730.
  • Meah N, Wall D, York K, et al. The Alopecia Areata Consensus of Experts (ACE) study: results of an international expert opinion on treatments for alopecia areata. J Am Acad Dermatol. 2020;83(1):123–130.
  • Phan K, Sebaratnam DF. JAK inhibitors for alopecia areata: a systematic review and meta-analysis. J Eur Acad Dermatol Venereol. 2019 May;33:850–856.
  • Dillon K-AL. A comprehensive literature review of JAK inhibitors in treatment of alopecia areata. Clin Cosmet Investig Dermatol. 2021 [cited 2021 Jul 21]; Available from 2021 Jul 21];14:691–714.
  • Kelly KA, Feldman SR. A wealth of new topicals for atopic dermatitis. J Dermatolog Treat. [Internet]. 2021 Jul 15 [cited 2021 Jul 21];1–4. Available from: https://pubmed-ncbi-nlm-nih-gov.go.libproxy.wakehealth.edu/34261409/ .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.